Avita Medical, Inc. - Common Stock — Bilan (NASDAQ:RCEL)

Afficher le graphique complet Full chart

Financials

Total de l'actif 125.5 M98.26 M111.64 M79.71 M56.39 M Total du passif 9.85 M12.97 M61.89 M74.97 M73.04 M Total des capitaux propres 115.66 M84.74 M49.06 M4.5 M-16.65 M Total du passif et des capitaux propres 125.5 M98.26 M111.64 M79.71 M56.39 M Dette totale ——39.81 M42.24 M42.98 M Dette nette ——39.81 M6.34 M-18.2 M

Avita Medical, Inc. - Common Stock

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

RCEL

Financials

Avita Medical, Inc. - Common Stock

Nouvelles

AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth Transcript

Le BPA de Avita Medical a manqué les attentes de 0,06$, le CA a surpassé les prévisions

AVITA Medical obtient l’autorisation réglementaire pour RECELL GO en Australie

AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript

Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?

AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL)

AVITA Medical obtient un contrat de 25,5 M$ avec BARDA pour les brûlures

Avita Medical à la conférence TD Cowen : Croissance et orientation stratégique

Avita Medical at TD Cowen Conference: Growth and Strategic Focus

Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade

Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know

AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript